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GENERAL COMMENTS
In my consideration, this is a well written and timely paper considering sociodemographics, and in further gender differences in suicidal behaviour among the older individuals. Although I have few comments.
General: 1. In some parts of the paper (e.g., p 16, lines 11-12; p 18, line 8), it seems that the authors already assume that these older individuals were prescribed antidepressants (ADs) for depression, although they have mentioned in the limitations that ADs might have been prescribed for other indication than depression (commonly demetia). Did the authors consider the ADs as a proxy for 'Depressive disorders'?,if yes then I think this could have been mentioned for better readership, otherwise, I would suggest to hold the discussion from the point of prescribed ADs rather than old age depression.
2. Another concern is 'sedatives and hypnotics'. Benzos are commonly prescribed to older individuals, which has been shown to be associated with suicidal behaviour, specially suicide. So, I was wondering if the authors have considered to somehow account for other psychotropic medications?
Specific: Methods: 1. I find it difficult to understand the categorization of 'country of birth'. The sub-group 'non-Nordic countries' can be a bit problematic, as because this group may include individuals from USA, Oceania, Table 3 shows the highest risk among 'Nordic countries (except Sweden)'; Table 5 shows non-nordic women and Nordic countries (except Sweden) men.
Page 17, lines 13-14: Please elaborate, it is not straight forward how life expectancy may matter here.
Page 17, lines 27-33 and page 18, lines 1-4: Well the paper is about the individuals aged from 75 or above, and majority were 80-89, around 20% had a high white collar job, so I assume that most of the individuals/ women were retired. So, would one not expect a relief from the job related stress factors in the retired life, or do the authors mean conflicting situation in the family life in the later ages of the retired life? As because the individuals who did not receive any ADs during the year before inclusion, so I assume they were not suffering from chronic depression, so how their suicidal behaviour can be related to the stress that they used to get years back from work? I consider that this part need a better clarity.
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GENERAL COMMENTS
This study breaks important new ground in its investigation of sociodemographic measures associated with completed suicides and suicide attempts, in a large population-based cohort study of adults aged 75 and older newly begun on antidepressant pharmacotherapy across a wide variety of clinical settings (ambulatory, inpatient, residential, general medical and mental health specialty). In addition to investigating the oldest old (who have generally been under-represented in prior studies), as well as country of origin, the analytic models stratify by gender to determine if sociodemographic factors are differentially associated with suicidal behavior in relation to gender (they are). Novel findings include the observations that suicide rates were found to be higher (1) amongst the young old than old old; (2) amongst immigrants; and (3) amongst women with higher education and/or prior occupational level. Other findings, such as higher rates amongst men and amongst those living alone replicate previous reports.
The authors' conclusions, that sociodemographic variables need to be understood within the risk and protective architecture for suicide among old and very old adults, are important and reasonable.
As the authors themselves have taught us in other studies, sociodemographic variables are important not only in and of themselves but also because they may point to or be proxies for other dimensions of risk for suicide in older adults. Examples would include impairments in executive functioning associated with depression, prolonged grief, and medical comorbidity/frailty/chronic pain amplified by depression. I suggest that this point be acknowledged or given greater weight in the Discussion.
The finding of higher rates of suicidal behavior among older, better educated women with higher prior occupational status reminds me of the higher rates of suicide amongst women physicians in the US compared with their male counterparts and with the general population. While we don't really understand the drivers of this association, it might be speculated that conflicting social roles, or the loss of social status in the context of retirement, could be salient drivers
Another issue meriting acknowledgment may be the relative lack of racial and ethnic heterogeneity in the Swedish cohort studied here, since suicide rates have been shown to vary by racial and ethnic status in other countries (including my home country, the US) in relation to gender.
Could the investigators provide information on type or class of antidepressant pharmacotherapy prescribed and taken? Some classes are safer than others, particularly in overdose.
In a related vein, can the investigators specify the mode of suicide, such as overdose, hanging, jumping, firearms?
Finally, although antidepressant pharmacotherapy is thought to be protective against suicidal behavior in older adults (in contrast to those under the age of 25), I wonder if the investigators are missing an opportunity to shed further light on this issue. In my clinical experience treating older adults with depression, I have occasionally encountered those in whom exposure to antidepressants seems to kindle or re-kindle suicidal ideation in the early phases of treatment. Can the investigators provide information about when suicidal behaviors occurred: early on, later on, or spread more or less evenly over time during the follow up period? Interval-specific risk might be clinically useful information in relation to the sociodemographic architecture described here.
Thank you for important work.
Charles F. Reynolds III MD University of Pittsburgh School of Medicine USA
VERSION 1 -AUTHOR RESPONSE
Reviewer #1:
In my consideration, this is a well-written and timely paper considering sociodemographics, and in further gender differences in suicidal behaviour among the older individuals.
Our response: We thank the reviewer for his positive consideration of our work.
General:
1. In some parts of the paper (e.g., p 16, lines 11-12; p 18, line 8), it seems that the authors already assume that these older individuals were prescribed antidepressants (ADs) for depression, although they have mentioned in the limitations that ADs might have been prescribed for other indication than depression (commonly dementia). Did the authors consider the ADs as a proxy for 'Depressive disorders'? If yes then I think this could have been mentioned for better readership, otherwise, I would suggest to hold the discussion from the point of prescribed ADs rather than old age depression.
Our answer:
We have now clarified the use of antidepressants in the introduction (page 4, line 22). It reads now: "Given that antidepressants are commonly indicated for depression, 13-15 their use may be considered as a proxy for depressive disorders".
We recently published findings regarding use of sedatives and hypnotics in this same cohort (Hedna et al; EJCP 2017), reporting increased risk of both fatal and non-fatal suicidal behavior among those who used these drug types. In the present paper, we focus on social factors and gender differences in risk factors for suicidal behavior in antidepressant users, rendering use of other psychotropic medications beyond the scope of the current study.
Specific:
Methods: 1. I find it difficult to understand the categorization of 'country of birth'. The sub-group 'non-Nordic countries can be a bit problematic, as because this group may include individuals from USA, Oceania, eastern Europe, western Europe, Africa, Asia and so on. It does not seem to be adequate to include someone from a high-income country, such as USA, Canada, Australia or New Zealand with someone from Somalia, Eritrea, or even South Asian. I suspect that the estimates might have been different and more informative if the non-Nordic could be categorized into other smaller groups. On the other hand, I understand that with such rare outcome as suicidal behaviour, it may not be statistically possible to have smaller groups due to power problem. In that case, the authors could have mentioned this, and could have explained why they decided to have such a broad group.
Our answer:
As the reviewer points out, suicidal behavior is a rare phenomenon and the low number of suicides and suicide attempts did not allow performing more detailed analysis by country of birth. The number of suicidal behaviours by region of birth is now presented in the supplementary table 1 of the manuscript.
We have also added the following text in the Discussion (Page 19, line 32): "Due to power issues, a more detailed analysis of region of birth was not possible. Data on suicides and attempted suicides by region of birth is reported in supplementary table S1".
2. Page 5, lines 10-11: the authors mention that the prescribed drug register includes information on purchased prescribed drugs for outpatients, residential care and nursing homes. I was wondering where did they obtain the data for index AD initiated at inpatient or hospital care. Or is the residential care synonymous to inpatient care? If so, then it is better to be consistent with terminology. My perception of residential care is if an elderly individual is being brought the ADs to home by a social worker. SO, please mention the data source for index AD if initiated at inpatient/hospital care.
Medications prescribed during inpatient hospital care are not included in the Swedish Prescribed Drug Register. We have added this limitation to the Discussion section (Page 19, Line 18): "The Swedish Prescribed Drug Register does not include drugs administered in a hospital setting which may lead to a slight misclassification of those who initiated their antidepressant therapy during their hospitalisation. However, only 4.3% of the study population had a record of depression in inpatient/outpatient specialised care during the year preceding their inclusion in the study. Further, antidepressant treatment initiated in hospital will in most cases be followed up with continuation treatment after discharge, and thus entered in the Prescribed Drug Register. This would suggest only a marginal effect on our findings".
3. I would like to ask if any sensitivity analysis was carried out before considering the undetermined intent. If only the X60-X84 were to be considered, would the estimates be different?
Our answer: In Sweden, it is common procedure to include cases with undetermined intent in suicide statistics to avoid underreporting. The number of events of undetermined intent was 13 for suicide attempts and 38 for suicide. Their exclusion would therefore have a limited effect on the conducted analyses.
Was there any interaction observed?
Our answer: One effect-modifier/interaction of concern was gender, and that effect was addressed by stratified analyses. No other interaction analysis was preformed since there is a significant number of possible interactions, and testing producers without theoretical or by model fit indicated grounds would undoubtedly lead to false significance, and is by itself of less scientific interest. A common reason to include interaction terms in non-linear models is to improve the fit of the models, but this did not deem as necessary in our case. Further, interactions in non-linear models, like Fine and Gray proportional hazard model, do not imply additive effect-modification, which would be an effect of higher interest. Finding new potential effect-modification could be of interest, but is beyond the scope of this paper.
5. In the Nordic countries, education is often used as a proxy of income. Here the authors had education, last employment and income level. Did the authors check for collinearity, would there be any possible over adjustment? However, it does affect the interpretation of the estimated effects. In the multivariate models, the estimates should be interpreted, as "the effect given that all other predictors are the same". Hence, e.g. the effect of annual income is given when compared with persons with the same occupation group and education level. Besides from the difference in interpretation, collinearity increases the variance hence decreases the power of the analysis. However, the variance inflation factor (VIF) was the highest for the variables levels of education and last occupation with values around 2, which is much lower than the commonly used cut-off of 5. In addition, when comparing the width of the confidence intervals in the crude and multivariable analysis (tables 3-5); the increase was deemed as acceptable. This is now discussed in the manuscript (page 19, line 4) and the suggested reference has been added: "Education, income, and last occupational class measure different social dimensions and tap into different causal mechanisms related to health. 42 Their possible correlation does not affect the validity of the regression models or other predictors. It may however decrease the statistical power of the analyses."
Results:
1. 
